Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesHenry Schein Inc

Henry Schein Inc

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
88.24 USD 0.00(0%)
Last update at 2026-11-04T21:00:00Z
VOLUME
3904208
Market Cap
9969.99M
P/E
25.89

Momentum Score

…

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
84.06
Low
88.48
High
52 Week Price Range
61.95
Low
92.18
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Henry Schein, Inc. is a global distributor of healthcare products and services serving dental and medical practitioners and offers practice management software and technology-enabled services. Long-term growth may be supported by steady demand for consumable supplies, increased adoption of digital care and practice solutions, and international expansion. Investors may find the company attractive for its scale, recurring revenue mix, and exposure to structural healthcare trends.

Principal investment risks include competitive pressure and margin compression, dependence on dental and medical market demand and reimbursement dynamics, execution risk from acquisitions and integrations, and potential regulatory or litigation exposure.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
88.24
Dividend Yield
-
Revenue TTM
13602.00M
Revenue Per Share
116.77
Gross Profit TTM
4260.00M
Debt / Equity
1.14
ROE
8.85%
Net Debt
3531.00M
ROCE
8.70%
Diluted EPS TTM
3.38

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 545.00M 526.00M 556.00M 721.00M 830.55M
Minority interest -21.00M -8.00M -25.00M 28.00M 29.29M
Net income 398.00M 390.00M 416.00M 538.00M 631.23M
Selling general administrative 3084.00M 3034.00M 2910.00M 2771.00M 2812.66M
Gross profit 3842.00M 3765.00M 3651.00M 3831.00M 3672.25M
Reconciled depreciation 281.00M 297.00M 232.00M 212.00M 209.53M
Ebit 695.00M 644.00M 629.00M 747.00M 851.66M
Ebitda 1006.00M 941.00M 877.00M 1108.00M 1075.62M
Depreciation and amortization 311.00M 297.00M 248.00M 361.00M 223.96M
Non operating income net other - - - 33.00M 33.82M
Operating income 758.00M 729.00M 714.00M 747.00M 851.66M
Other operating expenses 12426.00M 11944.00M 11625.00M 11769.00M 11541.43M
Interest expense 150.00M 131.00M 87.00M 44.00M 27.60M
Tax provision 126.00M 128.00M 134.00M 170.00M 197.35M
Interest income 33.00M 24.00M 24.00M 17.00M 6.45M
Net interest income -117.00M -107.00M -55.00M -27.00M -21.15M
Non recurring - - - - 7.94M
Income tax expense 126.00M 128.00M 120.00M 170.00M 197.35M
Total revenue 13184.00M 12673.00M 12339.00M 12647.00M 12401.02M
Total operating expenses 3084.00M 3036.00M 2937.00M 2953.00M 2812.66M
Cost of revenue 9342.00M 8908.00M 8688.00M 8816.00M 8728.77M
Total other income expense net -213.00M -203.00M -158.00M -26.00M -21.11M
Net income from continuing ops 419.00M 398.00M 470.00M 566.00M 660.53M
Net income applicable to common shares - - - 538.00M 631.23M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 11215.00M 10218.00M 10573.00M 8607.00M 8481.09M
Intangible assets 1018.00M 1023.00M 916.00M 587.00M 667.63M
Other current assets 655.00M 569.00M 639.00M 466.00M 413.10M
Total liab 6421.00M 5381.00M 5420.00M 3936.00M 4417.90M
Total stockholder equity 3245.00M 3393.00M 3655.00M 3446.00M 3425.13M
Deferred long term liab - - - 36.00M 42.28M
Other current liab 1199.00M 921.00M 1080.00M 1038.00M 1115.02M
Common stock 1.00M 1.00M 1.00M 1.00M 1.37M
Capital stock 1.00M 1.00M 1.00M 1.00M 1.37M
Retained earnings 3293.00M 3771.00M 3860.00M 3678.00M 3595.23M
Other liab - - - 397.00M 418.95M
Good will 4213.00M 3887.00M 3875.00M 2893.00M 2854.15M
Other assets - - - 232.00M 190.41M
Cash 156.00M 122.00M 171.00M 117.00M 117.97M
Total current liabilities 3228.00M 2803.00M 2683.00M 2224.00M 2306.51M
Current deferred revenue - 81.00M 89.00M - -
Net debt 3531.00M 2748.00M 2570.00M 1380.00M 1098.72M
Short term debt 875.00M 781.00M 494.00M 182.00M 137.56M
Short long term debt 797.00M 706.00M 414.00M 109.00M 61.17M
Short long term debt total 3687.00M 2870.00M 2741.00M 1497.00M 1216.68M
Other stockholder equity 177.00M - - -233.00M 1.37M
Property plant equipment - - - 667.00M 366.46M
Total current assets 4464.00M 3983.00M 4488.00M 3988.00M 3844.03M
Long term investments 174.00M 170.00M 180.00M 472.00M 423.87M
Net tangible assets - - - 542.00M 516.66M
Net receivables 1651.00M 1482.00M 1863.00M 1442.00M 1451.83M
Long term debt 2310.00M 1830.00M 1937.00M 1040.00M 811.35M
Inventory 2002.00M 1810.00M 1815.00M 1963.00M 1861.14M
Accounts payable 1154.00M 962.00M 1020.00M 1004.00M 1053.93M
Noncontrolling interest in consolidated entity - - - 649.00M 638.07M
Accumulated other comprehensive income -226.00M -379.00M -206.00M -233.00M -171.48M
Common stock total equity - - - 1.00M 1.37M
Retained earnings total equity - - - 3678.00M 3595.23M
Non currrent assets other 332.00M 284.00M 209.00M 223.00M -34.61M
Non current assets total 6751.00M 6235.00M 6085.00M 4619.00M 4637.06M
Capital lease obligations 329.00M 334.00M 390.00M 348.00M 344.17M
Long term debt total - - - 1040.00M 811.35M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -430.00M -873.00M 11.00M 5.67M
Change to liabilities - - - -96.00M 84.71M
Total cashflows from investing activities -477.00M -430.00M -1135.00M -276.00M -677.22M
Net borrowings 553.00M 189.00M 1053.00M 259.00M 161.43M
Total cash from financing activities -111.00M -510.00M 701.00M -315.00M -332.96M
Change to operating activities - - - -52.00M 9.06M
Net income 398.00M 398.00M 416.00M 566.00M 660.53M
Change in cash 34.00M -49.00M 54.00M -1.00M -303.22M
Begin period cash flow 122.00M 171.00M 117.00M 118.00M 421.19M
End period cash flow 156.00M 122.00M 171.00M 117.00M 117.97M
Total cash from operating activities 712.00M 848.00M 500.00M 602.00M 709.58M
Issuance of capital stock 250.00M 0.00M 0.00M - 0.00M
Depreciation 311.00M 268.00M 222.00M 212.00M 209.53M
Other cashflows from investing activities -10.00M -56.00M -55.00M -191.00M -603.87M
Dividends paid - - 2100.00M - -
Change to inventory -95.00M -59.00M 231.00M -126.00M -295.13M
Change to account receivables -124.00M 315.00M -327.00M -7.00M 4.16M
Sale purchase of stock -850.00M -385.00M -284.00M -485.00M -401.21M
Other cashflows from financing activities -64.00M -314.00M 85.00M 229.00M 208.93M
Change to netincome - - - 93.00M 38.67M
Capital expenditures 139.00M 187.00M 187.00M 96.00M 79.02M
Change receivables - - - -7.00M 4.16M
Cash flows other operating - - - -40.00M 7.11M
Cash and cash equivalents changes - - - 11.00M -300.59M
Change in working capital -48.00M 140.00M -234.00M -281.00M -197.20M
Stock based compensation 39.00M 39.00M 39.00M 54.00M 78.42M
Other non cash items 46.00M 59.00M 57.00M 112.00M -28.76M
Free cash flow 573.00M 661.00M 313.00M 506.00M 630.57M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HSIC
Henry Schein Inc		 -
-%		 88.24 25.89 15.08 0.72 3.14 1.00 13.43
MCK
McKesson Corporation		 69.82
6.98%		 1069.44 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 13.60
3.99%		 354.10 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc		 8.99
3.55%		 261.93 29.48 17.92 0.20 16.07 0.22 15.67
SHTDY
SINOPHARM GROUP CO LTD ADR		 0.11
1.04%		 10.69 6.18 7.49 0.01 0.76 0.03 0.72

Profile*

Henry Schein Inc

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

135 Duryea Road, Melville, NY, United States, 11747

631 843 5500

https://www.henryschein.com

25000

Name Title Year Born
Mr. Stanley M. Bergman Exec. Chairman & CEO 1950
Mr. James P. Breslawski Exec. Vice Chairman & Pres 1954
Mr. Steven Paladino Exec. Director 1957
Mr. Mark E. Mlotek Exec. VP, Chief Strategic Officer & Exec. Director 1956
Mr. Ronald N. South Sr. VP & CFO 1962
Mr. Michael Saul Ettinger Exec. VP & COO 1961
Ms. Olga Timoshkina VP of Corp. Fin., Chief Accounting Officer & Corp. Controller NA
Mr. Christopher Pendergast Sr. VP & CTO 1964
Graham Stanley VP of Investor Relations & Strategic Fin. Project Officer NA
Mr. Walter Siegel Sr. VP & Chief Legal Officer 1960

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…